» Articles » PMID: 25241254

Peptidoglycan Degrading Activity of the Broad-range Salmonella Bacteriophage S-394 Recombinant Endolysin

Overview
Journal Biochimie
Specialty Biochemistry
Date 2014 Sep 22
PMID 25241254
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The use of bacteriophage endolysins as specific antibacterial agents is a prospective strategy to treat bacterial infections caused by antibiotic-resistant pathogens. In case of Gram-negative species this strategy has limited applications since outer membrane shields the enzyme target and prevents bacteria lysis. We aimed to obtain and characterize the endolysin of the newly discovered anti-Salmonella bacteriophage S-394 (Lys394) and to choose an appropriate permeabilizing agent to disrupt Escherichia coli cells suspended in buffer solution and grown on agar surface. Lys394 synthesized in E. coli C41(DE3) was obtained as an electrophoretically homogenous protein. The protein of 18 kDa molecular weight shows high muralytic activity against various genera of chloroform treated Gram-negatives. Maximum of enzyme activity was observed at pH 8.5 and low ionic strength. In silico analysis of amino acid sequence identified Lys394 as an endopeptidase. Various outer membrane permeabilizers were analyzed in combination with Lys394 to degrade laboratory strain of E. coli CR63. Permeabilizing activity was evaluated using a periplasmic β-lactamase leakage test with untreated E. coli cells as a substrate. The highest rate of planktonic E. coli lysis was reached for Lys394 applied together with 25 μg/ml of poly-l-arginine with molecular weight distribution from 5 to 15 kDa or 20 μg/ml PGLa peptide. Lawn E. coli colony forming ability was decreased by 4 orders of magnitude after 30 min treatment with 25 μg of Lys394, 1 mM EDTA and 50 μg/ml of PGLa peptide at a room temperature.

Citing Articles

Role of hypothetical protein PA1-LRP in antibacterial activity of endolysin from a new phage PA1.

Tian Y, Xu X, Ijaz M, Shen Y, Shahid M, Ahmed T Front Microbiol. 2024; 15:1463192.

PMID: 39507333 PMC: 11538084. DOI: 10.3389/fmicb.2024.1463192.


A comprehensive review of the applications of bacteriophage-derived endolysins for foodborne bacterial pathogens and food safety: recent advances, challenges, and future perspective.

Khan F, Chen J, Zhang R, Liu B Front Microbiol. 2023; 14:1259210.

PMID: 37869651 PMC: 10588457. DOI: 10.3389/fmicb.2023.1259210.


Potential bacteriophages to overcome bacterial infection of Alcaligenes faecalis in diabetic ulcer.

Narulita E, Cahyati V, Febrianti R, Iqbal M Pediatr Endocrinol Diabetes Metab. 2023; 29(2):61-66.

PMID: 37728456 PMC: 10411081. DOI: 10.5114/pedm.2023.125363.


Cell Lysis Induced by Lys394 Enzyme Assisted by Magnetic Nanoparticles Exposed to Non-Heating Low-Frequency Magnetic Field.

Usvaliev A, Belogurova N, Pokholok K, Finko A, Prusov A, Golovin D Pharmaceutics. 2023; 15(7).

PMID: 37514057 PMC: 10384812. DOI: 10.3390/pharmaceutics15071871.


Identification of Three Campylobacter Lysins and Enhancement of Their Anti-Escherichia coli Efficacy Using Colicin-Based Translocation and Receptor-Binding Domain Fusion.

Liu P, Dong X, Cao X, Xie Q, Huang X, Jiang J Microbiol Spectr. 2023; :e0451522.

PMID: 36749047 PMC: 10100823. DOI: 10.1128/spectrum.04515-22.